Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
Cancer is a serious threat to human beings and is the second-largest cause of death all over the globe. Chemotherapy is one of the most common treatments for cancer; however, drug resistance and severe adverse effects are major problems associated with anticancer therapy. New compounds with multi-ta...
Saved in:
Main Authors: | Noor ul Amin Mohsin (Author), Sana Aslam (Author), Matloob Ahmad (Author), Muhammad Irfan (Author), Sami A. Al-Hussain (Author), Magdi E. A. Zaki (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris RE, et al.
Published: (2012) -
Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012) -
Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
by: Bruce P. Burnett, et al.
Published: (2011) -
Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors
by: Iqra Saleem Naz Babari, et al.
Published: (2024) -
Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin
by: Carla Fernandes, et al.
Published: (2017)